Acceptability Criteria of Precision Medicine: Lessons From Patients' Experiences With the GUIDE-IBD Trial Regarding the Use of Mobile Health Technology.

Anke ErdmannFlorian SchrinnerChristoph Rehmann-SutterAndre FrankeUrsula SeidlerStefan SchreiberClaudia Bozzaro

Published in: Crohn's & colitis 360 (2023)

Patients identified benefits, risks, and potentials for improvement, which should be considered in the further development of the devices and patient-reported outcome scales, and in the implementation of usual care.

Keyphrases

patient reported outcomes
end stage renal disease
ejection fraction
healthcare
chronic kidney disease
prognostic factors
primary care
randomized controlled trial
study protocol
pain management
health insurance